These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 8484020

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol.
    Zawalich WS, Zawalich KC.
    Metabolism; 1996 Feb; 45(2):273-8. PubMed ID: 8596502
    [Abstract] [Full Text] [Related]

  • 3. Insulinotropic effects of cholecystokinin, gastric inhibitory polypeptide and glucagon-like peptide-1 during perifusion of short-term cultured canine isolated islets.
    van der Burg MP, Guicherit OR, Frölich M, Gooszen HG.
    Regul Pept; 1995 Dec 07; 60(1):61-7. PubMed ID: 8747785
    [Abstract] [Full Text] [Related]

  • 4. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness.
    Delmeire D, Flamez D, Moens K, Hinke SA, Van Schravendijk C, Pipeleers D, Schuit F.
    Biochem Pharmacol; 2004 Jul 01; 68(1):33-9. PubMed ID: 15183115
    [Abstract] [Full Text] [Related]

  • 5. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC, Göke R, Göke B, Bächle R, Wagner B, Arnold R.
    Biochim Biophys Acta; 1991 Feb 19; 1091(3):356-63. PubMed ID: 1705823
    [Abstract] [Full Text] [Related]

  • 6. The effects of glucagon-like peptide-I (GLP-I) on hormone secretion from isolated human pancreatic islets.
    Fehmann HC, Hering BJ, Wolf MJ, Brandhorst H, Brandhorst D, Bretzel RG, Federlin K, Göke B.
    Pancreas; 1995 Aug 19; 11(2):196-200. PubMed ID: 7479679
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39.
    Edwards CM, Todd JF, Mahmoudi M, Wang Z, Wang RM, Ghatei MA, Bloom SR.
    Diabetes; 1999 Jan 19; 48(1):86-93. PubMed ID: 9892226
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of pyruvic acid methyl ester on rat pancreatic islets. Effects on insulin secretion, phosphoinositide hydrolysis, and sensitization of the beta cell.
    Zawalich WS, Zawalich KC.
    J Biol Chem; 1997 Feb 07; 272(6):3527-31. PubMed ID: 9013600
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glucagon-like peptide 1 and fatty acids amplify pulsatile insulin secretion from perifused rat islets.
    Cunningham BA, Richard AM, Dillon JS, Daley JT, Civelek VN, Deeney JT, Yaney GC, Corkey BE, Tornheim K.
    Biochem J; 2003 Jan 01; 369(Pt 1):173-8. PubMed ID: 12356335
    [Abstract] [Full Text] [Related]

  • 15. Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells.
    Sjöholm A, Sandberg E, Ostenson CG, Efendić S.
    Pancreas; 2000 Apr 01; 20(3):282-9. PubMed ID: 10766455
    [Abstract] [Full Text] [Related]

  • 16. GLP-1(7-36) amide stimulates insulin secretion in rat islets: studies on the mode of action.
    Fridolf T, Ahrén B.
    Diabetes Res; 1991 Apr 01; 16(4):185-91. PubMed ID: 1802486
    [Abstract] [Full Text] [Related]

  • 17. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
    Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R.
    Endocrinology; 2003 Dec 01; 144(12):5149-58. PubMed ID: 12960095
    [Abstract] [Full Text] [Related]

  • 18. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets.
    Laychock SG.
    Mol Cell Endocrinol; 1995 Aug 30; 113(1):19-28. PubMed ID: 8674810
    [Abstract] [Full Text] [Related]

  • 19. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
    Gutniak MK, Juntti-Berggren L, Hellström PM, Guenifi A, Holst JJ, Efendic S.
    Diabetes Care; 1996 Aug 30; 19(8):857-63. PubMed ID: 8842604
    [Abstract] [Full Text] [Related]

  • 20. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM, MacDonald PE, Gaisano HY, Wheeler MB.
    Mol Endocrinol; 1999 Aug 30; 13(8):1305-17. PubMed ID: 10446905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.